FUSION PROTEIN COMPRISING THE WHOLE OR PART OF THE PP65 PROTEIN OF HUMAN CMV, USEABLE IN PARTICULAR FOR PREPARING A VACCINE

摘要

The invention concerns a fusion protein characterised in that it comprises at least part of the pp65 protein of the cytomegalovirus (or CMV), or a protein having at least 80% homology with the pp65 protein, in combination with at least a second peptide fragment derived from CMV. The invention also concerns a nucleotide sequence coding for such a protein, or a pharmaceutical composition containing them. It further concerns its use as medicine and a method for preparing the protein.